These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27899215)

  • 1. Toxicology in international drug control-Prioritizing the most harmful, persistent and prevalent substances.
    Ifeagwu SC; Raithelhuber M; Crean C; Gerostamoulos D; Chung H; Tettey JN
    Forensic Sci Int; 2017 May; 274():2-6. PubMed ID: 27899215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New psychoactive substances: An actual problem or an overestimated phenomenon?
    Vaiano F; Pascali JP; Bertol E
    Forensic Sci Int; 2019 Nov; 304():109941. PubMed ID: 31574421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of new psychoactive substances in Northeast Asia from 2007 to 2015.
    Lee J; Yang S; Kang Y; Han E; Feng LY; Li JH; Chung H
    Forensic Sci Int; 2017 Mar; 272():1-9. PubMed ID: 28088088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
    Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
    Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of intoxication with novel psychoactive substance (NPS) in Pomeranian region, from January to July 2015].
    Kabata P; Schetz D; Waldman W; Wiergowsk M; Sein Anand J
    Przegl Lek; 2015; 72(10):517-21. PubMed ID: 26946558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An expanding world of new psychoactive substances-designer benzodiazepines.
    Zawilska JB; Wojcieszak J
    Neurotoxicology; 2019 Jul; 73():8-16. PubMed ID: 30802466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single chemical entity legal highs: assessing the risk for long term harm.
    McNabb CB; Russell BR; Caprioli D; Nutt DJ; Gibbons S; Dalley JW
    Curr Drug Abuse Rev; 2012 Dec; 5(4):304-19. PubMed ID: 23244343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO Expert Committee on Drug Dependence. Thirty-sixth report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2015; (991):1-50, back cover. PubMed ID: 26062388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New psychoactive substances: challenges for drug surveillance, control, and public health responses.
    Peacock A; Bruno R; Gisev N; Degenhardt L; Hall W; Sedefov R; White J; Thomas KV; Farrell M; Griffiths P
    Lancet; 2019 Nov; 394(10209):1668-1684. PubMed ID: 31668410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.
    Helander A; Bäckberg M
    Clin Toxicol (Phila); 2017 Jan; 55(1):1-3. PubMed ID: 27549399
    [No Abstract]   [Full Text] [Related]  

  • 11. Death cases involving certain new psychoactive substances: A review of the literature.
    Kraemer M; Boehmer A; Madea B; Maas A
    Forensic Sci Int; 2019 May; 298():186-267. PubMed ID: 30925344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
    Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project.
    Helander A; Bäckberg M; Beck O
    PLoS One; 2020; 15(4):e0232038. PubMed ID: 32324788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rise of new psychoactive substance use in Australia.
    Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The comprehensive investigation of the new psychoactive substances].
    Andreev AI; Malkova TL; Apushkin DY; Bulatov IP; Mashchenko PS
    Sud Med Ekspert; 2016; 59(2):55-58. PubMed ID: 27070039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drug controls and reduced hospital presentations due to novel psychoactive substances in Edinburgh.
    Pettie J; Burt A; Knipe DW; Torrance H; Dow M; Osinski K; Greig R; Sabatini D; Easterford K; Dear J; Eddleston M
    Br J Clin Pharmacol; 2018 Oct; 84(10):2303-2310. PubMed ID: 29911343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective.
    Tettey JNA; Crean C; Ifeagwu SC; Raithelhuber M
    Handb Exp Pharmacol; 2018; 252():51-67. PubMed ID: 29896655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New psychoactive substances: catalysing a shift in forensic science practice?
    Tettey J; Crean C
    Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1674):. PubMed ID: 26101290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.
    Smith CD; Robert S
    Clin Med (Lond); 2014 Aug; 14(4):409-15. PubMed ID: 25099844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3-year review of new psychoactive substances in casework.
    Elliott S; Evans J
    Forensic Sci Int; 2014 Oct; 243():55-60. PubMed ID: 24810679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.